كنان الطرح: أنشأ الصفحة ب'{{Navbox | name = Signaling peptide/protein receptor modulators | title = Signaling peptide/protein receptor modulators | st...'

2017-09-03T08:01:24Z

أنشأ الصفحة ب'{{Navbox | name = Signaling peptide/protein receptor modulators | title = Signaling peptide/protein receptor modulators | st...'

صفحة جديدة

{{Navbox
| name = Signaling peptide/protein receptor modulators
| title = [[Peptide receptor|Signaling peptide/protein receptor]] [[receptor modulator|modulator]]s
| state = {{{state<includeonly>|collapsed</includeonly>}}}
| bodyclass = hlist
| groupstyle = text-align:center;
| border = {{{border|}}}

| group1 = [[Adiponectin receptor|Adiponectin]]
| list1 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Adiponectin receptor 1|AdipoR1]]
| list1 =
* ''Agonists:'' ''Peptide:'' [[Adiponectin]]
* [[ADP-355]]
* [[ADP-399]]; ''Non-peptide:'' [[AdipoRon]]
* [[(–)-Arctigenin]]
* [[Arctiin]]
* [[Gramine]]
* [[Matairesinol]]

* ''Antagonists:'' ''Peptide:'' [[ADP-400]]

| group2 = [[Adiponectin receptor 2|AdipoR2]]
| list2 =
* ''Agonists:'' ''Peptide:'' [[Adiponectin]]
* [[ADP-355]]
* [[ADP-399]]; ''Non-peptide:'' [[AdipoRon]]
* [[Deoxyschizandrin]]
* [[Parthenolide]]
* [[Syringing (drug)|Syringing]]
* [[Taxifoliol]]

* ''Antagonists:'' ''Peptide:'' [[ADP-400]]

}}

| group2 = [[Angiotensin receptor|Angiotensin]]
| list2 =
* ''Agonists:'' [[Angiotensin II]]
* [[Angiotensin III]]
* [[Angiotensin IV]]
* [[Saralasin]]

* ''Antagonists:'' [[Abitesartan]]
* [[Azilsartan]]
* [[Azilsartan medoxomil]]
* [[Candesartan]]
* [[Elisartan]]
* [[Embusartan]]
* [[Eprosartan]]
* [[EXP-3174]]
* [[Fimasartan]]
* [[Forasartan]]
* [[Irbesartan]]
* [[Losartan]]
* [[Milfasartan]]
* [[Olmesartan]]
* [[Olmesartan medoxomil]]
* [[Olodanrigan]]
* [[PD123319]]
* [[Pomisartan]]
* [[Pratosartan]]
* [[Ripisartan]]
* [[Saprisartan]]
* [[Sparsentan]]
* [[Tasosartan]]
* [[Telmisartan]]
* [[Valsartan]]
* [[Zolasartan]]

* ''ACE inhibitors:'' [[Alacepril]]
* [[Benazepril]]
* [[Captopril]]
* [[Cilazapril]]
* [[Delapril]]
* [[Enalapril]]
* [[Enalaprilat]]
* [[Fosinopril]]
* [[Gemopatrilat]]
* [[Imidapril]]
* [[Lisinopril]]
* [[Moexipril]]
* [[Omapatrilat]]
* [[Perindopril]]
* [[Quinapril]]
* [[Quinaprilat]]
* [[Ramipril]]
* [[Rentiapril]]
* [[Rescinnamine]]
* [[Spirapril]]
* [[Spiraprilat]]
* [[Temocapril]]
* [[Trandolapril]]
* [[Zofenopril]]
* [[Zofenoprilat]]

* ''Renin inhibitors:'' [[Aliskiren]]
* [[Ciprokiren]]
* [[Ditekiren]]
* [[Enalkiren]]
* [[Pepstatin]]
* [[Remikiren]]
* [[Terlakiren]]
* [[Zankiren]]

* ''Propeptides:'' [[Angiotensinogen]]
* [[Angiotensin I]]

| group3 = [[Bradykinin receptor|Bradykinin]]
| list3 =
* ''Agonists:'' [[Bradykinin]]
* [[Kallidin]]

* ''Antagonists:'' [[FR-173657]]
* [[Icatibant]]
* [[LF22-0542]]

| group4 = [[Calcitonin gene-related peptide receptor|CGRP]]
| list4 =
* ''Agonists:'' [[Amylin]]
* [[Calcitonin gene-related peptide|CGRP]]
* [[Pramlintide]]

* ''Antagonists:'' [[Atogepant]]
* [[BI 44370 TA]]
* [[CGRP (8-37)]]
* [[MK-3207]]
* [[Olcegepant]]
* [[Rimegepant]]
* [[SB-268262]]
* [[Telcagepant]]
* [[Ubrogepant]]

* ''Antibodies:'' [[Erenumab]]

| group5 = [[Cholecystokinin_receptor|Cholecystokinin]]
| list5 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Cholecystokinin A receptor|CCKA]]
| list1 =
* ''Agonists:'' [[Cholecystokinin]]

* ''Antagonists:'' [[Amiglumide]]
* [[Asperlicin]]
* [[Devazepide]]
* [[Dexloxiglumide]]
* [[Lintitript]]
* [[Lorglumide]]
* [[Loxiglumide]]
* [[Pranazepide]]
* [[Proglumide]]
* [[Tarazepide]]
* [[Tomoglumide]]

| group2 = [[Cholecystokinin B receptor|CCKB]]
| list2 =
* ''Agonists:'' [[Cholecystokinin]]
* [[CCK-4]]
* [[Gastrin]]
* [[Pentagastrin|Pentagastrin (CCK-5)]]

* ''Antagonists:'' [[Ceclazepide]]
* [[CI-988|CI-988 (PD-134308)]]
* [[Itriglumide]]
* [[L-365,360]]
* [[Netazepide]]
* [[Proglumide]]
* [[Spiroglumide]]

| group3 = Unsorted
| list3 =
* ''Antagonists:'' [[Nastorazepide]]

}}

| group6 = [[Corticotropin-releasing hormone receptor|CRH]]
| list6 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Corticotropin releasing hormone receptor 1|CRF1]]
| list1 =
* ''Agonists:'' [[Cortagine]]
* [[Corticorelin]]
* [[Corticotropin releasing hormone]]
* [[Sauvagine]]
* [[Stressin I]]
* [[Urocortin]]

* ''Antagonists:'' [[Antalarmin]]
* [[Astressin-B]]
* [[CP-154,526]]
* [[Emicerfont]]
* [[Hypericin]]
* [[LWH-234]]
* [[NBI-27914]]
* [[Pexacerfont]]
* [[R-121919]]
* [[TS-041]]
* [[Verucerfont]]

| group2 = [[Corticotropin releasing hormone receptor 2|CRF2]]
| list2 =
* ''Agonists:'' [[Corticorelin]]
* [[Corticotropin releasing hormone]]
* [[Sauvagine]]
* [[Urocortin]]

* ''Antagonists:'' [[Astressin-B]]

}}

| group7 = [[Cytokine receptor|Cytokine]]
| list7 = See [[Template:Cytokine receptor modulators|here]] instead.

| group8 = [[Endothelin receptor|Endothelin]]
| list8 =
* ''Agonists:'' [[Endothelin 1]]
* [[Endothelin 2]]
* [[Endothelin 3]]
* [[IRL-1620]]

* ''Antagonists:'' [[A-192621]]
* [[ACT-132577]]
* [[Ambrisentan]]
* [[Aprocitentan]]
* [[Atrasentan]]
* [[Avosentan]]
* [[Bosentan]]
* [[BQ-123]]
* [[BQ-788]]
* [[Clazosentan]]
* [[Darusentan]]
* [[Edonentan]]
* [[Enrasentan]]
* [[Fandosentan]]
* [[Feloprentan]]
* [[Macitentan]]
* [[Nebentan]]
* [[Sitaxentan]]
* [[Sparsentan]]
* [[Tezosentan]]
* [[Zibotentan]]

| group9 = [[Galanin receptor|Galanin]]
| list9 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Galanin receptor 1|GAL1]]
| list1 =
* ''Agonists:'' [[Galanin]]
* [[Galanin (1-15)]]
* [[Galanin-like peptide]]
* [[Galmic]]
* [[Galnon]]

* ''Antagonists:'' [[C7 (drug)|C7]]
* [[Dithiepine-1,1,4,4-tetroxide]]
* [[Galantide|Galantide (M15)]]
* [[M32 (drug)|M32]]
* [[M35 (drug)|M35]]
* [[M40 (drug)|M40]]
* [[SCH-202596]]

| group2 = [[Galanin receptor 2|GAL2]]
| list2 =
* ''Agonists:'' [[Galanin]]
* [[Galanin (1-15)]]
* [[Galanin (2-11)]]
* [[Galanin-like peptide]]
* [[Galmic]]
* [[Galnon]]
* [[J18 (drug)|J18]]

* ''Antagonists:'' [[C7 (drug)|C7]]
* [[Galantide|Galantide (M15)]]
* [[M32 (drug)|M32]]
* [[M35 (drug)|M35]]
* [[M40 (drug)|M40]]
* [[M871 (drug)|M871]]

| group3 = [[Galanin receptor 3|GAL3]]
| list3 =
* ''Agonists:'' [[Galanin]]
* [[Galanin (1-15)]]
* [[Galmic]]
* [[Galnon]]

* ''Antagonists:'' [[C7 (drug)|C7]]
* [[Galantide|Galantide (M15)]]
* [[GalR3ant]]
* [[HT-2157]]
* [[M32 (drug)|M32]]
* [[M35 (drug)|M35]]
* [[M40 (drug)|M40]]
* [[SNAP-37889]]
* [[SNAP-398299]]

}}

| group10 = [[Growth hormone secretagogue receptor|Ghrelin/GHS]]
| list10 =
* See [[Template:GH/IGF-1 axis signaling modulators|here]] instead.

| group11 = [[Growth hormone receptor|GH]]
| list11 =
* See [[Template:GH/IGF-1 axis signaling modulators|here]] instead.

| group12 = [[Growth-hormone-releasing hormone receptor|GHRH]]
| list12 =
* See [[Template:GH/IGF-1 axis signaling modulators|here]] instead.

| group13 = [[Glucagon-like peptide receptor|GLP]]
| list13 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Glucagon-like peptide 1 receptor|GLP-1]]
| list1 =
* ''Agonists:'' [[Albiglutide]]
* [[Beinaglutide]]
* [[Dulaglutide]]
* [[Efpeglenatide]]
* [[Exenatide]]
* [[Glucagon-like peptide 1|GLP-1]]
* [[Langlenatide]]
* [[Liraglutide]]
* [[Lixisenatide]]
* [[Oxyntomodulin]]
* [[Semaglutide]]
* [[Taspoglutide]]

| group2 = [[Glucagon-like peptide 2 receptor|GLP-2]]
| list2 =
* ''Agonists:'' [[Elsiglutide]]
* [[Glepaglutide]]
* [[Glucagon-like peptide 2|GLP-2]]
* [[Teduglutide]]

| group3 = Others
| list3 =
* ''Propeptides:'' [[Preproglucagon]]
* [[Proglucagon]]

}}

| group14 = [[Glucagon receptor|Glucagon]]
| list14 =
* ''Agonists:'' [[Dasiglucagon]]
* [[Glucagon]]
* [[Oxyntomodulin]]

* ''Antagonists:'' [[Adomeglivant]]
* [[L-168,049]]
* [[LGD-6972]]

* ''Propeptides:'' [[Preproglucagon]]
* [[Proglucagon]]

| group15 = [[Gonadotropin-releasing hormone receptor|GnRH]]
| list15 =
* ''Agonists:'' ''Peptide:'' [[Avorelin]]
* [[Buserelin|Buserelin (buserelin acetate)]]
* [[Deslorelin]]
* [[Fertirelin|Fertirelin (fertirelin acetate)]]
* [[Gonadorelin]]
* [[Gonadotropin-releasing hormone|GnRH (LHRH, gonadorelin)]]
* [[Goserelin|Goserelin (goserelin acetate)]]
* [[Histrelin]]
* [[Leuprorelin|Leuprorelin (leuprolide acetate)]]
* [[Lutrelin]]
* [[Nafarelin]]
* [[Peforelin]]
* [[Triptorelin]]
* [[Zoptarelin doxorubicin]]

* ''Antagonists:'' ''Peptide:'' [[Abarelix]]
* [[Acyline]]
* [[Cetrorelix]]
* [[Degarelix]]
* [[Detirelix]]
* [[Ganirelix]]
* [[Iturelix]]
* [[Ozarelix]]
* [[Prazarelix]]
* [[Ramorelix]]
* [[Teverelix|Teverelix (antarelix)]]; ''Non-peptide:'' [[ASP-1707]]
* [[Elagolix]]
* [[KLH-2109|KLH-2109 (OBE-2109)]]
* [[Relugolix]]
* [[Sufugolix]]

| group16 = [[Gonadotropin receptor|Gonadotropin]]
| list16 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Luteinizing hormone/choriogonadotropin receptor|LH/CG]]
| list1 =
* ''Agonists:'' [[Choriogonadotropin alfa]]
* [[Human chorionic gonadotropin]]
* [[Luteinizing hormone]]
* [[Lutropin alfa]]
* [[Menotropin|Menotropin (human menopausal gonadotropin)]]

| group2 = [[Follicle-stimulating hormone receptor|FSH]]
| list2 =
* ''Agonists:'' [[Corifollitropin alfa]]
* [[Follicle-stimulating hormone]]
* [[Follitropin alfa]]
* [[Follitropin beta]]
* [[Follitropin epsilon]]
* [[Menotropin|Menotropin (human menopausal gonadotropin)]]
* [[Urofollitropin]]
* [[Varfollitropin alfa]]

* ''{{abbr|NAMs|negative allosteric modulators}}:'' [[ADX-61623]]

}}

| group17 = [[Growth factor receptor|Growth factor]]
| list17 = See [[Template:Growth factor receptor modulators|here]] instead.

| group18 = [[Insulin receptor|Insulin]]
| list18 =
* ''Agonists:'' [[Chaetochromin|Chaetochromin (4548-G05)]]
* [[Insulin-like growth factor 1]]
* [[Insulin-like growth factor 2]]
* [[Insulin]]
* [[Insulin aspart]]
* [[Insulin degludec]]
* [[Insulin detemir]]
* [[Insulin glargine]]
* [[Insulin glulisine]]
* [[Insulin lispro]]
* [[Mecasermin]]
* [[Mecasermin rinfabate]]

* ''Antagonists:'' [[BMS-754807]]
* [[S661]]
* [[S961]]

* ''Kinase inhibitors:'' [[Linsitinib]]

* ''Antibodies:'' [[Xentuzumab]] (against IGF-1 and IGF-2)

| group19 = [[KiSS1-derived peptide receptor|Kisspeptin]]
| list19 =
* ''Agonists:'' [[Kisspeptin]]
* [[Kisspeptin-10]]

* ''Antagonists:'' [[Kisspeptin-234]]

| group20 = [[Leptin receptor|Leptin]]
| list20 =
* ''Agonists:'' [[Leptin]]
* [[Metreleptin]]

| group21 = [[Melanin-concentrating hormone receptor|MCH]]
| list21 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Melanin-concentrating hormone receptor 1|MCH1]]
| list1 =
* ''Agonists:'' [[Melanin concentrating hormone]]

* ''Antagonists:'' [[ATC-0065]]
* [[ATC-0175]]
* [[GW-803430]]
* [[NGD-4715]]
* [[SNAP-7941]]
* [[SNAP-94847]]

| group2 = [[Melanin-concentrating hormone receptor 2|MCH2]]
| list2 =
* ''Agonists:'' [[Melanin concentrating hormone]]

}}

| group22 = [[Melanocortin receptor|Melanocortin]]
| list22 =
* See [[Template:Melanocortin receptor modulators|here]] instead.

| group23 = [[Neuropeptide FF receptor|Neuropeptide FF]]
| list23 =
* ''Agonists:'' [[Neuropeptide AF]]
* [[Neuropeptide FF]]
* [[Neuropeptide SF|Neuropeptide SF (RFRP-1)]]
* [[Neuropeptide VF|Neuropeptide VF (RFRP-3)]]

* ''Antagonists:'' [[BIBP-3226]]
* [[RF9 (drug)|RF9]]

| group24 = [[Neuropeptide S receptor|Neuropeptide S]]
| list24 =
* ''Agonists:'' [[Neuropeptide S]]

* ''Antagonists:'' [[ML-154]]
* [[SHA-68]]

| group25 = [[Neuropeptide Y receptor|Neuropeptide Y]]
| list25 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Neuropeptide Y receptor Y1|Y1]]
| list1 =
* ''Agonists:'' [[Neuropeptide Y]]
* [[Peptide YY]]

* ''Antagonists:'' [[BIBO-3304]]
* [[BIBP-3226]]
* [[BVD-10]]
* [[GR-231118]]
* [[PD-160170]]

| group2 = [[Neuropeptide Y receptor Y2|Y2]]
| list2 =
* ''Agonists:'' [[2-Thiouridine 5'-triphosphate]]
* [[Neuropeptide Y]]
* [[Neuropeptide Y (13-36)]]
* [[Peptide YY]]
* [[Peptide YY (3-36)]]

* ''Antagonists:'' [[BIIE-0246]]
* [[JNJ-5207787]]
* [[SF-11]]

| group3 = [[Pancreatic polypeptide receptor 1|Y4]]
| list3 =
* ''Agonists:'' [[GR-231118]]
* [[Neuropeptide Y]]
* [[Pancreatic polypeptide]]
* [[Peptide YY]]

* ''Antagonists:'' [[UR-AK49]]

| group4 = [[Neuropeptide Y receptor Y5|Y5]]
| list4 =
* ''Agonists:'' [[BWX-46]]
* [[Neuropeptide Y]]
* [[Peptide YY]]

* ''Antagonists:'' [[CGP-71683]]
* [[FMS-586]]
* [[L-152,804]]
* [[Lu AA-33810]]
* [[MK-0557]]
* [[NTNCB]]
* [[Velneperit|Velneperit (S-2367)]]

}}

| group26 = [[Neurotensin receptor|Neurotensin]]
| list26 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Neurotensin receptor 1|NTS1]]
| list1 =
* ''Agonists:'' [[Neurotensin]]
* [[Neuromedin N]]

* ''Antagonists:'' [[Meclinertant]]
* [[SR-142948]]

| group2 = [[Neurotensin receptor 2|NTS2]]
| list2 =
* ''Agonists:'' [[Neurotensin]]

* ''Antagonists:'' [[Levocabastine]]
* [[SR-142948]]

}}

| group28 = [[Opioid receptor|Opioid]]
| list28 = See [[Template:Opioid receptor modulators|here]] instead.

| group29 = [[Orexin receptor|Orexin]]
| list29 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Hypocretin (orexin) receptor 1|OX1]]
| list1 =
* ''Agonists:'' [[Orexin]] ([[Orexin-A|A]], [[Orexin-B|B]])

* ''Antagonists:'' [[ACT-335827]]
* [[ACT-462206]]
* [[Almorexant]]
* [[Filorexant]]
* [[Lemborexant]]
* [[SB-334867]]
* [[SB-408124]]
* [[SB-649868]]
* [[Suvorexant]]
* [[TCS-1102]]

| group2 = [[Hypocretin (orexin) receptor 2|OX2]]
| list2 =
* ''Agonists:'' [[Orexin]] ([[Orexin-A|A]], [[Orexin-B|B]])
* [[SB-668875]]

* ''Antagonists:'' [[ACT-335827]]
* [[ACT-462206]]
* [[Almorexant]]
* [[EMPA (drug)|EMPA]]
* [[Filorexant]]
* [[JNJ-10397049]]
* [[Lemborexant]]
* [[MK-1064]]
* [[SB-649868]]
* [[Seltorexant]]
* [[Suvorexant]]
* [[TCS-1102]]
* [[TCS-OX2-29]]

}}

| group30 = [[Oxytocin receptor|Oxytocin]]
| list30 =
* See [[Template:Oxytocin and vasopressin receptor modulators|here]] instead.

| group31 = [[Prolactin receptor|Prolactin]]
| list31 =
* ''Agonists:'' [[Growth hormone]]
* [[Human placental lactogen]]
* [[Placental growth hormone|Placental growth hormone (growth hormone variant)]]
* [[Prolactin]]
* [[S179D-hPRL]]
* [[Somatotropin]]

* ''Antagonists:'' [[Δ1–9-G129R-hPRL]]
* [[Δ1–14-G129R-hPRL]]
* [[G120K-hGH]]
* [[G129R-hPRL]]

* ''Prolactin modulators:'' ''Prolactin inhibitors:'' [[D2 receptor|D2 receptor]] [[agonist]]s (e.g., [[bromocriptine]], [[cabergoline]]); ''Prolactin releasers:'' [[D2 receptor|D2 receptor]] [[receptor antagonist|antagonist]]s (e.g., [[domperidone]], [[metoclopramide]], [[risperidone]])
* [[Estrogen]]s (e.g., [[estradiol]])
* [[Progestogen]]s (e.g., [[progesterone]])

| group32 = [[Parathyroid hormone receptor|PTH]]
| list32 =
* ''Agonists:'' [[Abaloparatide]]
* [[Parathyroid hormone]]
* [[Parathyroid hormone-related protein|Parathyroid hormone-related protein (PTHrP)]]
* [[Semparatide]]
* [[Teriparatide]]

| group33 = [[Relaxin receptor|Relaxin]]
| list33 =
* ''Agonists:'' [[INSL3|Insulin-like factor 3]]
* [[Relaxin]] ([[Relaxin-1|1]], [[Relaxin-2|2]], [[Relaxin-3|3]])
* [[Serelaxin]]

| group34 = [[Somatostatin receptor|Somatostatin]]
| list34 =
* See [[Template:GH/IGF-1 axis signaling modulators|here]] instead.

| group35 = [[Tachykinin receptor|Tachykinin]]
| list35 =
* See [[Template:Neurokinin receptor modulators|here]] instead.

| group36 = [[Thyrotropin-releasing hormone receptor|TRH]]
| list36 =
* ''Agonists:'' [[Azetirelin]]
* [[Fertirelin]]
* [[Montirelin]]
* [[Orotirelin]]
* [[Posatirelin]]
* [[Protirelin]]
* [[Rovatirelin]]
* [[Taltirelin]]
* [[Thyrotropin-releasing hormone|TRH (TRF)]]

| group37 = [[Thyrotropin receptor|TSH]]
| list37 =
* ''Agonists:'' [[Thyrotropin alfa]]
* [[Thyroid-stimulating hormone|TSH (thyrotropin)]]

| group38 = [[Vasopressin receptor|Vasopressin]]
| list38 =
* See [[Template:Oxytocin and vasopressin receptor modulators|here]] instead.

| group39 = [[Vasoactive intestinal peptide receptor|VIP]]/[[Pituitary adenylate cyclase-activating peptide|PACAP]]
| list39 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[VIPR1|VIPR1]]
| list1 =
* ''Agonists:'' ''Peptide:'' [[Bay 55-9837]]
* [[LBT-3393]]
* [[Pituitary adenylate cyclase-activating peptide|PACAP]]
* [[Vasoactive intestinal peptide|VIP]]

| group2 = [[VIPR2|VIPR2]]
| list2 =
* ''Agonists:'' ''Peptide:'' [[LBT-3627]]
* [[Pituitary adenylate cyclase-activating peptide|PACAP]]
* [[Vasoactive intestinal peptide|VIP]]

| group3 = [[ADCYAP1R1|PAC1]]
| list3 =
* ''Agonists:'' [[Pituitary adenylate cyclase-activating peptide|PACAP]]
* [[PACAP (1-27)]]
* [[PACAP (1-38)]]

* ''Antagonists:'' [[PACAP (6-38)]]

| group4 = Unsorted
| list4 =
* [[Peptide histidine isoleucineamide|PHI]]
* [[Peptide histidine methionineamide|PHM]]
* [[Peptide histidine valine|PHV]]

}}

| group40 = Others
| list40 =
* ''Endogenous:'' [[Adrenomedullin]]
* [[Apelin]]
* [[Asprosin]]
* [[Bombesin]]
* [[Calcitonin]]
* [[Carnosine]]
* [[Cocaine and amphetamine regulated transcript|CART]]
* [[Corticotropin-like intermediate peptide|CLIP]]
* [[Delta sleep-inducing peptide|DSIP]]
* [[Enteroglucagon]]
* [[Formyl peptide]]
* [[Galanin-like peptide|GALP]]
* [[Gastric inhibitory polypeptide|GIP]]
* [[Gastrin-releasing peptide|GRP]]
* [[Integrin]] ligands ([[collagen]]s, [[fibrinogen]], [[fibronectin]], [[laminin]]s, [[ICAM-1]], [[ICAM-2]], [[osteopontin]], [[VCAM-1]], [[vitronectin]])
* [[Kininogen]]s
* [[Motilin]]
* [[Natriuretic peptide]]s ([[Atrial natriuretic peptide|ANP]], [[Brain natriuretic peptide|BNP]], [[C-type natriuretic peptide|CNP]], [[urodilatin]])
* [[Nesfatin-1]]
* [[Neuromedin B]]
* [[Neuromedin N]]
* [[Neuromedin S]]
* [[Neuromedin U]]
* [[Obestatin]]
* [[Osteocalcin]]
* [[Resistin]]
* [[Secretin]]
* [[Thymopoietin]]
* [[Thymosin]]s
* [[Thymulin]]
* [[Urotensin-II]]
* [[VGF]]

* ''Exogenous:'' [[Lifitegrast]] (LFA-1 antagonist)

| below =
;See also
: ''[[Template:Receptor modulators|Receptor/signaling modulators]]''

}}<noinclude>
{{collapsible option}}
[[Category:Drug templates by receptor, channel, or pump]]
</noinclude>

قالب:Signaling peptide/protein receptor modulators - تاريخ المراجعة

كنان الطرح: أنشأ الصفحة ب'{{Navbox | name = Signaling peptide/protein receptor modulators | title = Signaling peptide/protein receptor modulators | st...'